Sign in

CIK 0001178670 · Large accelerated filer

ALNYLAM PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ALNY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
770602661
Phone
(617) 551-8200
Business address
675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
Former names
ALNYLAM PHARMACEUTICALS INC
Open-market buys, last 90 days
$543,126
in 2 filings
Open-market sales, last 90 days
$398,855
in 1 filing

Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-10-02 Garg Pushkal EVP Chief R&D Sale 10b5-1 −147 $457.43 $67K 23,246
2025-10-02 Garg Pushkal EVP Chief R&D Sale 10b5-1 −3 $457.64 $1K 23,243
2025-10-01 SUPRAN BRYAN EVP, CLO and Secretary Grant or award +13,026 13,026
2025-10-01 Poulton Jeffrey V. EVP, Chief Financial Officer Grant or award +3,108 53,229
2025-10-01 Poulton Jeffrey V. EVP, Chief Financial Officer Grant or award +4,644 57,873
2025-10-01 Greenstreet Yvonne Chief Executive Officer Grant or award +3,860 60,081
2025-10-01 Greenstreet Yvonne Chief Executive Officer Grant or award +14,252 74,333
2025-10-01 Tanguler Tolga EVP, Chief Commercial Officer Grant or award +2,851 28,843
2025-10-01 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Grant or award +2,102 24,821
2025-10-01 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Grant or award +2,851 27,672
2025-10-01 Garg Pushkal EVP Chief R&D Grant or award 10b5-1 +3,108 23,329
2025-10-01 Garg Pushkal EVP Chief R&D Grant or award 10b5-1 +2,851 26,180
2025-09-09 Reitan Colleen F Director Option exercise 10b5-1 +18,000 $100.65 $1.8M 18,775
2025-09-09 Reitan Colleen F Director Sale 10b5-1 −1,645 $457.44 $752K 17,130
2025-09-09 Reitan Colleen F Director Sale 10b5-1 −1,888 $458.86 $866K 15,242
2025-09-09 Reitan Colleen F Director Sale 10b5-1 −1,403 $459.73 $645K 13,839
2025-09-09 Reitan Colleen F Director Sale 10b5-1 −473 $460.71 $218K 13,366
2025-09-09 Reitan Colleen F Director Sale 10b5-1 −2,290 $461.92 $1.1M 11,076
2025-09-09 Reitan Colleen F Director Sale 10b5-1 −1,652 $463.00 $765K 9,424
2025-09-09 Reitan Colleen F Director Sale 10b5-1 −799 $464.36 $371K 8,625

Page 22 of 41 · 816 trades